AU2005302501A1 - Spontaneously dispersible pharmaceutical compositions - Google Patents

Spontaneously dispersible pharmaceutical compositions Download PDF

Info

Publication number
AU2005302501A1
AU2005302501A1 AU2005302501A AU2005302501A AU2005302501A1 AU 2005302501 A1 AU2005302501 A1 AU 2005302501A1 AU 2005302501 A AU2005302501 A AU 2005302501A AU 2005302501 A AU2005302501 A AU 2005302501A AU 2005302501 A1 AU2005302501 A1 AU 2005302501A1
Authority
AU
Australia
Prior art keywords
solid
pharmaceutical composition
peg
component
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005302501A
Other languages
English (en)
Inventor
Michael Ambuhl
Ping Li
Barbara Luckel
Madhusudhan Pudipeddi
Sara Royce Hynes
Alan Edward Royce
Abu T. M. Serajuddin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2005302501A1 publication Critical patent/AU2005302501A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2005302501A 2004-10-29 2005-10-27 Spontaneously dispersible pharmaceutical compositions Abandoned AU2005302501A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62334504P 2004-10-29 2004-10-29
US62334404P 2004-10-29 2004-10-29
US60/623,344 2004-10-29
US60/623,345 2004-10-29
PCT/US2005/039004 WO2006050123A1 (en) 2004-10-29 2005-10-27 Spontaneously dispersible pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU2005302501A1 true AU2005302501A1 (en) 2006-05-11

Family

ID=35876536

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005302501A Abandoned AU2005302501A1 (en) 2004-10-29 2005-10-27 Spontaneously dispersible pharmaceutical compositions

Country Status (9)

Country Link
US (1) US20080064760A1 (enExample)
EP (1) EP1807049A1 (enExample)
JP (1) JP2008518931A (enExample)
KR (1) KR20070069172A (enExample)
AU (1) AU2005302501A1 (enExample)
BR (1) BRPI0518239A2 (enExample)
CA (1) CA2578854A1 (enExample)
MX (1) MX2007005124A (enExample)
WO (1) WO2006050123A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2663558C (en) * 2006-09-26 2013-05-28 Samyang Corporation Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
MX2009005947A (es) * 2006-12-05 2009-06-17 Novartis Ag Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas.
WO2008092084A2 (en) 2007-01-26 2008-07-31 Centocor, Inc. Injectable non-aqueous suspension with high concentration of therapeutic agent
SG10201503234SA (en) 2010-05-03 2015-06-29 Teikoku Pharma Usa Inc Non-Aqueous Taxane Pro-Emulsion Formulations and Methods of Making and Using the Same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
CA2284000C (en) * 1997-03-12 2012-01-03 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US6828301B2 (en) * 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
WO2004047673A2 (en) * 2002-11-21 2004-06-10 Novacea, Inc. Treatment of liver disease with active vitamin d compounds

Also Published As

Publication number Publication date
JP2008518931A (ja) 2008-06-05
CA2578854A1 (en) 2006-05-11
MX2007005124A (es) 2007-06-22
EP1807049A1 (en) 2007-07-18
US20080064760A1 (en) 2008-03-13
BRPI0518239A2 (pt) 2008-11-11
KR20070069172A (ko) 2007-07-02
WO2006050123A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
US8722664B2 (en) Spontaneously dispersible N-benzoyl staurosporine compositions
TWI248368B (en) Composition in form of emulsion or microemulsion pre-concentrate for oral administration and its uses
US20070190132A1 (en) Pharmaceutical compositions for oral and topical administration
JP2005515996A (ja) 活性型ビタミンｄ化合物を含む薬学的組成物
CZ20014214A3 (cs) Cyklosporinové prostředky v podstatě prosté oleje
EP0985412B1 (en) Cyclosporin compositions
AU2007333355B2 (en) Microemulsion dosage forms of valsartan and methods of making the same
EP1151755B1 (en) Pharmaceutical compositions comprising cyclosporin as active ingredient
KR101928589B1 (ko) 알리스포리비르를 포함하는 제약 조성물
US20080064760A1 (en) Spontaneously Dispersible Pharmaceutical Composition
CN101048137A (zh) 可自发分散的药物组合物
KR20050011323A (ko) 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물
AU2009202703A1 (en) Pharmaceutical compositions for oral and topical administration

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted